Carborane derivative development for boron neutron capture therapy. Final report
Boron Neutron Capture Therapy [BNCT] is a binary method of cancer therapy based on the capture of neutrons by a boron-10 atom [{sup 10}B]. Cytotoxic {sup 7}Li nuclei and {alpha}-particles are emitted, with a range in tissue of 9 and 5 {micro}m, respectively, about one cell diameter. The major obstacle to clinically viable BNCT is the selective localization of 5-30 ppm {sup 10}B in tumor cells required for effective therapy. A promising approach to BNCT is based on hydrophilic boron-rich oligomeric phosphate diesters, or ''trailers'' that have been shown to concentrate selectively in tumor tissue. Examples of these compounds were prepared previously at high cost using an automated DNA synthesizer. Direct synthesis methods are needed for the production of gram-scale quantities for further biological evaluation. The work accomplished as a result of the collaboration between Fluorochem, Inc. and UCLA demonstrates that short oligomers containing at least five carborane units with four phosphodiester linkages can be prepared in substantial quantities. This work was accomplished by the application of standard phosphoramidite coupling chemistry.
- Research Organization:
- Fluorochem, Inc., Azusa, CA 91702-5122 (US)
- Sponsoring Organization:
- US Department of Energy (US)
- DOE Contract Number:
- FG03-98ER82580
- OSTI ID:
- 762720
- Resource Relation:
- Other Information: PBD: 1 Apr 1999
- Country of Publication:
- United States
- Language:
- English
Similar Records
Boron-Containing Compounds for Liposome-Mediated Tumor Localization and Application to Neutron Capture Therapy
Simple, high-yield synthesis of polyhedral carborane amino acids